Popular Mover to Observe-: Inovio Pharmaceuticals, Inc. (INO)

INO Stock Price Comparison to Moving Averages:

USA based company, Inovio Pharmaceuticals, Inc. (INO)’s latest closing price distance was at -15.87% from the average-price of 200 days while it maintained a distance from the 50 Day Moving Average at -21.99% and -24.04% compared with the 20 Day Moving Average.

Analysts Mean Rating:

Analysts’ mean recommendation for Inovio Pharmaceuticals, Inc. (INO) stands at 1.80. Rating Scale; where 1.0 rating means Strong Buy, 2.0 rating signify Buy, 3.0 recommendation reveals Hold, 4.0 rating score shows Sell and 5.0 displays Strong Sell signal.

Performance Review:

To review the INO previous performance, look at its past history, which highlighted below:

During last 5 trades the stock sticks almost -24.50%.

During last one month it showed the change of -24.59%.

During last 3 month it remained at -1.96%.

Along with these its year to date performance is standing at -13.40%.

Important Technical Indicators:

ATR value of company was 0.34. Relative Strength Index (RSI) was 25.61. Developed J. Welles Wilder, the Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. Traditionally, and according to Wilder, RSI is considered overbought when above 70 and oversold when below 30. Signals can also be generated by looking for divergences, failure swings and centerline crossovers. RSI can also be used to identify the general trend.

The stock volatility for week was 4.83% while for month was 3.73%.The stock, as of last close, traded 3.09% to its 52 week low and was changed -45.36% from its 52 week high. Beta factor, which measures the riskiness of the security, was observed as 2.87. INO’s value Change from Open was at -4.15% with a Gap of -7.52%.

Earnings per share Details about INO:

EPS in next five year years is expected to touch 0.00% while EPS growth in past 5 year was -15.80% along with sales growth of 29.30% in the last five years.

EPS growth in next year is estimated to reach -25.50% while EPS growth estimate for this year is set at -135.30%.


Inovio Pharmaceuticals, Inc. (INO)’s Stock Price Trading Update:

Inovio Pharmaceuticals, Inc. (INO), a part of Healthcare sector and belongs to Biotechnology industry; ended its day with loss -11.36% and finalized at the price of $6.01. During its last trading session, Stock traded with the total exchanged volume of 15.77 million shares. The average volume stands around 1.61 million shares. The average numbers of shares are traded in a security per day, during the recent 3-month period. The stock has relative volume of 9.80. Relative volume is ratio between current volume and 3-month average value, intraday adjusted.


Leave a Reply

Your email address will not be published. Required fields are marked *